Suppression of MicroRNA-125a-5p Upregulates the TAZ-EGFR Signaling Pathway and Promotes Retinoblastoma Proliferation
Overview
Affiliations
Retinoblastoma is the most common intraocular malignancy that occurs during childhood; however, the mechanism underlying retinoblastoma proliferation and progression remains unclear. MicroRNAs (miRNAs) play an important role in the regulation of a myriad of biological processes in various types of cancer. In this study, we performed microarray analysis followed by qRT-PCR using four classes of retinoblastoma tissues with increasing cTNM classification stages to identify crucial miRNAs whose expression was correlated with retinoblastoma progression. miR-125a-5p was downregulated, and its expression levels were inversely correlated with cell proliferation in retinoblastoma compared with adjacent non-tumor retinal tissues. The overexpression of miR-125a-5p significantly suppressed cell proliferation and tumor formation in retinoblastoma. We further identified the transcriptional co-activator with PDZ binding motif (TAZ) as a direct target of miR-125a-5p. Importantly, TAZ levels were inversely correlated with miRNA-125a-5p expression, and TAZ promoted retinoblastoma cell proliferation. Moreover, the overexpression of miR-125a-5p led to a decrease in TAZ expression and downstream EGFR signaling pathway activation both in vitro and vivo. Finally, TAZ overexpression in retinoblastoma cells overexpressing miR-125a-5p restored retinoblastoma cell proliferation and EGFR pathway activation. Taken together, our data demonstrated that miR-125a-5p functions as an important tumor suppressor that suppresses the EGFR pathway by targeting TAZ to inhibit tumor progression in retinoblastoma. Thus, the miR-125a-5p/TAZ/EGFR axis may be a potential therapeutic target for retinoblastoma.
Esmaeili M, Smith D, Mead B Sci Rep. 2024; 14(1):31895.
PMID: 39738601 PMC: 11685716. DOI: 10.1038/s41598-024-83381-9.
Interaction of noncoding RNAs with hippo signaling pathway in cancer cells and cancer stem cells.
Abedimanesh S, Safaralizadeh R, Jahanafrooz Z, Najafi S, Amini M, Nazarloo S Noncoding RNA Res. 2024; 9(4):1292-1307.
PMID: 39045083 PMC: 11263728. DOI: 10.1016/j.ncrna.2024.06.006.
The Hippo signalling pathway and its impact on eye diseases.
Du Y J Cell Mol Med. 2024; 28(8):e18300.
PMID: 38613348 PMC: 11015399. DOI: 10.1111/jcmm.18300.
Sadri F, Hosseini S, Rezaei Z, Fereidouni M Genes Dis. 2023; 11(2):760-771.
PMID: 37692482 PMC: 10491881. DOI: 10.1016/j.gendis.2023.01.017.
MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?.
Yang H, Liu Y, Chen L, Zhao J, Guo M, Zhao X Biomolecules. 2023; 13(6).
PMID: 37371458 PMC: 10295928. DOI: 10.3390/biom13060877.